Table 1 Clinical characteristics in subjects with different stages of glucose tolerance

Age(year)

45 ± 10

46 ± 13

48 ± 13

44 ± 12

0.093

Female(%)

22(46.8)

21(40.4)

26(51.0)

28(46.7)

0.886

BMI(kg/m²)

24.8 ± 3.4

25.2 ± 2.8

24.7 ± 2.5

25.0 ± 4.4

0.182

SBP(mmHg)

119 ± 12

126 ± 13*

125 ± 15*

132 ± 18*

0.001

DBP(mmHg)

75 ± 10

77 ± 9

79 ± 10*

80 ± 8*

0.015

TG(mmol/L)

1.4(0.8–2.2)

1.5(0.9–2.5)

1.9(1.1–3.3)*‡

1.8(1.4–4.0)*‡

0.002

TC(mmol/L)

4.5 ± 1.2

4.7 ± 1.0

5.1 ± 1.3*

5.3 ± 2.0*‡

0.022

HDL-C(mmol/L)

1.4 ± 0.4

1.2 ± 0.3*

1.1 ± 0.3*

1.1 ± 0.3*

0.013

LDL-C(mmol/L)

2.3 ± 0.8

2.5 ± 0.8

2.8 ± 1.0*‡

2.6 ± 0.7*

0.020

HbA1c(%)

5.3 ± 0.5

6.3 ± 1.1*

7.6 ± 1.6*‡

8.9 ± 1.8*‡§

0.000

ISI

168(122–222)

131(97–203)*

108(74–162)*‡

92(67–142)*‡

0.002

ΔI30/ΔG30

4.5(3.7–5.8)

2.6(1.4–4.4)*

1.6(1.1–3.1)*‡

1.0(0.5–1.9)*‡§

0.000

oral disposition index

745(546–947)

362(271–475)*

203(134–274)*‡

91(70–139)*‡§

0.000

SD(mmol/L)

0.9 ± 0.3

1.5 ± 0.5*

1.9 ± 0.6*‡

2.2 ± 0.6*‡§

0.000

MBG(mmol/L)

5.9 ± 0.5

6.7 ± 0.7*

7.7 ± 1.0*‡

8.7 ± 1.5*‡§

0.000

HBGI

0.8(0.2–1.2)

2.0(1.2–3.7)*

3.8(2.4–5.6)*‡

6.4(3.2–9.5)*‡§

0.000

CONGA1(mmol/L)

1.0 ± 0.2

1.3 ± 0.2*

1.5 ± 0.3*‡

1.8 ± 0.4*‡§

0.000

MODD(mmol/L)

0.9 ± 0.3

1.4 ± 0.4*

1.8 ± 0.7*‡

2.1 ± 0.7*‡§

0.000

MAGE(mmol/L)

2.1 ± 0.6

3.3 ± 1.0*

4.3 ± 1.4*‡

4.8 ± 1.6*‡§

0.000